Roche AD Taxi: Biomarkers for the diagnosis of late-stage dementia: Are we there yet? – Dr Diana Kerwin
07 Jun 2022
Biomarkers for the diagnosis of late-stage dementia: Are we there yet? Dr Diana Kerwin – Kerwin Medical Centre, Dallas, Texas, USA
Neurology
Follow Us
Newsletter
Keep up to date with our latest
articles and journals
Alzheimer’s Disease
Latest Videos
Roche AD Taxi: Biomarkers and the AD continuum – Prof. Henrik Zetterberg
01 Jun 2022
Biomarkers and the AD continuum Prof. Henrik Zetterberg – Institute of Neuroscience and Physiology, University of Gothenburg, Sweden.
Roche AD Taxi: How can we support primary care physicians with an AD diagnosis? – Dr Diana Kerwin
31 May 2022
How can we support primary care physicians with an AD diagnosis? Dr Diana Kerwin – Kerwin Medical Centre, Dallas, Texas, USA
Roche AD Taxi: An introduction to biomarkers in AD – Prof. Henrik Zetterberg
17 May 2022
An introduction to biomarkers in AD Prof. Henrik Zetterberg – Institute of Neuroscience and Physiology, University of Gothenburg, Sweden.
Alzheimer Europe 2020 Conference Round table discussion: Maintaining dementia as a European priority
23 Feb 2021
Round table discussion: “Maintaining dementia as a European priority” Moderator: Jim Pearson (United Kingdom) With the participation of • Maria Carrillo (Alzheimer’s...
Alzheimer Europe 2020 Conference – Special symposium – My second new life: adapting after COVID-19
23 Feb 2021
Chairperson: Helen Rochford-Brennan (Ireland) With the participation of: • Idalina Aguiar (Portugal) • Stefan Eriksson (Sweden) • Tomaž Gržinič (Slovenia) • Carol...
Alzheimer Europe 2020 Conference, Opening & Roundtable discussion: Dementia in a changing world
23 Feb 2021
Welcome and introductory comments by • Iva Holmerová, Chairperson, Alzheimer Europe • Helen Rochford-Brennan, Chairperson, European Working Group of People with...
Ten Tips for Preventing Alzheimer’s Disease
24 Nov 2020
Alzheimer’s disease is the sixth leading cause of death for people over the age of sixty-five. We can’t slow it down once you are diagnosed, and we...
Living with Alzheimer’s disease
20 Nov 2020
Cindy Leonard, a longtime Mayo Clinic nurse and nurse educator, was diagnosed with young-onset Alzheimer’s disease in 2018. It’s an uncommon form of...
Alzheimer disease – an Osmosis Preview
31 Oct 2020
Watch the full video, for free, here! https://osms.it/alzheimer_disease What is Alzheimer disease? Alzheimer disease disease is a neurodegenerative disease that leads...
What’s the connection between sleep and Alzheimer’s disease? | Sleeping with Science
02 Sep 2020
Does not getting enough sleep lead to Alzheimer’s disease? Sleep scientist Matt Walker explains the relationship between the two — and how researchers are...
Avatar image Ageing and Alzheimer’s disease: the search for the cure
21 Aug 2020
During this online lecture Professor Ashley Bush will review the latest exciting progress in Alzheimer’s and ageing research at the Florey. At the Florey we have...
Alzheimer’s Disease: What You Need to Know – The #COVID19 Edition
01 Jul 2020
Watch this presentation from Stony Brook Medicine neuropsychologist Christopher Christodoulou, PhD, where he explains Alzheimer’s disease, prevention and...
Ten Warning Signs of Alzheimer’s Disease
23 Jun 2020
A lot of us have been home during the COVID-19 pandemic. Maybe you’re interacting with your older relatives more than usual and you may be noticing some memory...
Studies Bolster Alzheimer’s Amyloid Hypothesis
17 Oct 2017
Two new studies appear to lend strong support for the theory that an overabundance of the amyloid-beta protein is the root cause of Alzheimer’s disease. A genetic study...
Medical Food, Supplement Appear Helpful for Dementias
24 Jul 2012
Medical foods and supplements designed to support neural health and function may soon expand treatment options for common forms of dementia based on the results of two...
Experimental Drug Improves Cognition, Memory in Alzheimer’s
24 Jul 2012
An investigational drug has shown promise in improving memory and cognition in patients with mild to moderate Alzheimer’s disease in a 6-month, randomized,...
Panel Discusses Direction of Alzheimer’s Disease Research
19 Jul 2012
Neurologists Dr. Richard Caselli and Dr. Marwan Sabbagh discuss the direction of Alzheimer’s disease research and some of the hot topics at the 2012 Alzheimer’s...
Sleep Problems May Increase Risk for Dementia
18 Jul 2012
Disordered sleep in mid- to late life is associated with an increased risk for future cognitive impairment and may alter the dynamics of the Alzheimer’s...
Federal Funds Launch First Alzheimer’s Prevention Study
16 May 2012
The first-ever primary prevention trial for Alzheimer’s disease will investigate whether immunotherapy can delay – or even stop – the disease in a group of subjects who...
Latest Posts
Alzheimer Europe Press release: Alzheimer Europe report outlines challenges associated with legal capacity and dementia
31 Jan 2024
The objective of the “Yearbook 2023” is to provide an overview of the situation in Europe relating to legal capacity and supported...
NHS England releases new resources on intercultural dementia care including a joint guide with Alzheimer Europe
22 Aug 2023
NHS England releases new resources on intercultural dementia care including a joint guide with Alzheimer Europe
28 Jun 2023
The number of people living with dementia from an ethnic minority background is expected to double by 2026 in England. Currently, people...
33rd Alzheimer Europe Conference agenda available online and new bursaries also available for early stage researchers!
28 Jun 2023
Alzheimer Europe and Muistiliitto (Alzheimer Society of Finland) would like to thank everyone who submitted abstracts for the 33rd...
17-19 October: 32nd Alzheimer Europe Conference takes place in Bucharest and online under the banner “Building bridges”, bringing together 544 participants from 42 countries
14 Dec 2022
Alzheimer Europe hosts European Parliament Lunch Debate examining EU and WHO policies on neurological conditions
29 Aug 2022
Alzheimer Europe publishes two new reports: One on sex, gender and sexuality in the context of dementia, and one on dementia-inclusive initiatives and communities
22 Mar 2022
Alzheimer Europe has launched a new report on sex, gender and sexuality in the context of dementia, targeted at health and social care...
“Resilience in dementia: Moving beyond the COVID-19 pandemic” brings together over 600 participants from 38 countries
13 Jan 2022
During greatest public health crisis in living memory, European Commission adopts first Work Plan of new EU4Health Programme undermining key activities of European health NGOs
06 Aug 2021
Alzheimer Europe position regarding the prioritisation of people with dementia for COVID-19 vaccination
07 May 2021
Background Alzheimer Europe position regarding the prioritisation of people with dementia for COVID-19 vaccination Adopted by the...
New Alzheimer Europe report identifies key recommendations on legal capacity and decision making of people with dementia
09 Mar 2021
Luxembourg, 9 March 2021 – Today, Alzheimer Europe launches a new report, “Legal capacity and decision making: The ethical implications of...
Alzheimer Europe sets out recommendations to improve data sharing in dementia research
23 Feb 2021
Alzheimer Europe sets out recommendations to improve data sharing in dementia research Luxembourg, 23 February 2021 – At an online...
Help Make Real Change Happen For People Living With Dementia – Sign The Glasgow Declaration!
26 Oct 2015
Alzheimer Europe (AE) is an NGO and has been raising awareness of all forms of dementia since 1996. It operates a common European platform...
Optogenetic Manipulation Of The Cholinergic System: Potential Implications For The Treatment Of Memory Deficits In Alzheimer’s Disease
13 May 2015
Successful treatment of psychiatric disorders and neurodegenerative diseases depends crucially on our fundamental knowledge of how...
Exercise May Be The Best Medicine For Alzheimer’s
02 Aug 2013
New research out of the University of Maryland School of Public Health shows that exercise may improve cognitive function in those at risk...
A Second Amyloid Could Play A Role In Alzheimer’s Disease
28 Jun 2013
A protein secreted with insulin travels through the bloodstream and accumulates in the brains of individuals with type 2 diabetes and...
Drugs Found To Both Prevent And Treat Alzheimer’s Disease In Mice
01 Jun 2013
Scientists hope the pharmaceuticals could lead to the development of a silver bullet for combatting the neurodegenerative disease....
Uncontrolled Hypertension Could Bring Increased Risk For Alzheimer’s Disease
20 Mar 2013
A study in the journal, JAMA Neurology suggests that controlling or preventing risk factors such as hypertension earlier in life may limit...
Buphenyl Identified As A Possible Drug For Alzheimer’s Disease
09 Mar 2013
Buphenyl, an FDA-approved medication for hyperammonemia, may protect memory and prevent the progression of Alzheimer’s disease....
High-Risk Alzheimer’s Gene Increases Risk Of Other Dementias
26 Nov 2012
In addition to raising the risk of Alzheimer’s disease, the apolipoprotein E e4 allele appears to confer strong risks for Lewy body and...
Studies Identify Early Changes In Familial Alzheimer’s Disease
11 Nov 2012
Young adult carriers of the presenilin gene mutation that invariably induces Alzheimer’s disease around the age of 45 years already show...
Ahead Of The Journals: Discontinuing Risperidone In AD
22 Oct 2012
The medical illustration is provided courtesy of Alzheimer’s Disease Research, a program of...
Alzheimer’s Imaging Agent Considered For Medicare Coverage
15 Oct 2012
The imaging agent florbetapir F 18 injection (Amyvid), used to exclude a diagnosis of Alzheimer’s disease, is being evaluated for Medicare...
Clinical, Social Barriers Cripple Adequate Alzheimer’s Care
25 Sep 2012
Physicians in five countries agree: Those who diagnose and treat patients with Alzheimer’s disease need more – and better – tools to...
Changing How We Prescribe Antipsychotics for Dementia
01 Sep 2012
The vast majority of patients with Alzheimer’s disease will show agitation, delusion, and other disruptive behaviors during the course of...
Biomarkers May Aid Differential Diagnosis of Dementias, Parkinsonism
28 Aug 2012
Measurements of five protein biomarkers in the cerebrospinal fluid helped to differentiate Alzheimer’s disease from Parkinson’s disease...
Alzheimer’s Drug Misses Primary End Points in Trials
25 Aug 2012
Eli Lilly’s experimental Alzheimer’s drug solanezumab failed to have statistically significant benefits in the primary end...
Coffee Consumption Linked to Lower Dementia Risk in Elderly
18 Aug 2012
Long-term coffee consumption may protect against dementia in the elderly, according to an Italian study presented at the Alzheimer’s...
Skin Cancer Drug Steps Into New Alzheimer’s Study
17 Aug 2012
The first human trial of bexarotene, the skin cancer drug shown to clear beta-amyloid brain plaques in mice with Alzheimer’s-like...
Environment Modifies ApoE e4-Related Risk of Alzheimer’s Disease
15 Aug 2012
Potentially modifiable environmental factors protect against Alzheimer’s disease in older adults carrying the apolipoprotein E e4 allele,...
Neuropsychological Data Endorse Preclinical Alzheimer’s
09 Aug 2012
The first evidence of emerging Alzheimer’s disease surfaces at least 1 decade before the onset of the disorder, based on new...
Nondrug Interventions Can Improve Dementia Patients’ Lives
08 Aug 2012
Nonpharmacologic interventions bestow clinically meaningful benefits on patients with dementia, a literature review has concluded. But...
Psychosis in Alzheimer’s May Recur After Dropping Risperidone
07 Aug 2012
When Alzheimer’s disease patients who took risperidone for psychoses discontinued the drug, they were more than four times more likely to...
Benefit of IVIG in Alzheimer’s Disease Appears Durable
20 Jul 2012
Intravenous immunoglobulin continues to slow the decline in cognitive and other functions seen in Alzheimer’s disease for at least 3...
Blood Test May Predict Alzheimer’s in Cognitively Impaired
19 Jul 2012
An investigational gene-based blood test identified prodromal Alzheimer’s disease with an accuracy of 81%. The test is based on a panel of...
Genome Sequencing Set to Hunt for Alzheimer’s Clues
07 Jul 2012
The largest-ever genome sequencing project is the newest weapon in the Alzheimer’s battle. This new project will examine the genetic codes...
Delirium Hits Hard in Hospitalized Alzheimer’s Patients
19 Jun 2012
Approximately one in eight Alzheimer’s disease patients who develop delirium while hospitalized will suffer at least one adverse outcome,...
Onset Periods of Depression Linked to Different Dementias
20 May 2012
Recurrent depression from midlife through late life increases the risk of vascular dementia, suggesting a progressive etiologic...
National Plan Aims to Eliminate Alzheimer’s By 2025
17 May 2012
A new plan marshals the forces of funding, research, and education to fight the battle against Alzheimer’s. The National Plan to Address...
Amyloid Imaging Agent May Aid Alzheimer’s Diagnosis
12 Apr 2012
The Food and Drug Administration’s approval of the first amyloid plaque-imaging agent, florbetapir F18, may usher in a “new...
Monitoring Antipsychotic Side Effects Infrequent Among Dementia Patients
28 Mar 2012
Monitoring for metabolic side effects proved to be infrequent for outpatients with dementia or delirium who had been prescribed...
Continuing Donepezil Appears Best for Some Alzheimer’s Patients
08 Mar 2012
Patients with moderate or severe Alzheimer’s disease who continued to worsen despite treatment with donepezil appeared to retain a small...
Study Suggests New Potential Alzheimer’s Treatment Strategy
18 Feb 2012
A pharmacotherapeutic approach that harnesses the amyloid-beta clearing effects of the apolipoprotein E gene while also activating...
Antibody Reduces Amyloid-Beta in Alzheimer’s
14 Nov 2011
Major Finding: Monthly infusion with 200 mg gantenerumab, a monoclonal antibody to amyloid-beta, resulted in an average 15% decline in the...